Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Tracking Breast Density Changes Over Time Enhances Cancer Risk Prediction
Research & Development Tracking Breast Density Changes Over Time Enhances Cancer Risk Prediction

Breast density is a significant factor in both the risk of developing breast cancer and the effectiveness of mammographic tumor detection. While it is common for breast density to decrease with age, certain patterns of density increase are associated with heightened cancer risk. This article delves

Can Selective Gene Inactivation Explain Disease Variability?
Research & Development Can Selective Gene Inactivation Explain Disease Variability?

Traditionally, it is believed that each cell contains two copies of each gene, one from each parent, playing equal parts in cellular functions. This new study challenges that notion by revealing that some cells exhibit a bias and inactivate one parental gene copy over the other. This phenomenon,

Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279
Research & Development Takeda Advances Psoriasis Treatment with Oral TYK2 Inhibitor TAK-279

Psoriasis, often misunderstood as merely a skin condition, is a complex immune-mediated disease impacting around 125 million individuals globally. This systemic condition demands comprehensive treatment strategies that go beyond addressing superficial skin symptoms. Dr. Graham Heap, Vice President

Is Clozapine Safe for Schizophrenia Patients Regarding Blood Cancer Risks?
Research & Development Is Clozapine Safe for Schizophrenia Patients Regarding Blood Cancer Risks?

The notable effectiveness of clozapine in treating schizophrenia has placed it as the sole FDA-approved option for patients resistant to other treatments. However, despite its advantages, concerns have lingered due to studies suggesting a potential association between clozapine use and an increased

Australia's Digital Health Leap: 2025 EHR Vendor Rankings Unveiled
Tech & Innovation Australia's Digital Health Leap: 2025 EHR Vendor Rankings Unveiled

Australia has made significant strides in the adoption of electronic health records (EHR), transforming its healthcare landscape and bringing the nation to the forefront of digital health innovation. Despite being a latecomer compared to other developed nations, Australia's extensive efforts

Can Stem Cell Therapy Effectively Treat Neurodegenerative Diseases?
Research & Development Can Stem Cell Therapy Effectively Treat Neurodegenerative Diseases?

The concept of treating neurodegenerative diseases with stem cell therapy has captivated the medical community for decades, presenting a potential breakthrough in the race to cure diseases like Alzheimer's, Parkinson's, and multiple sclerosis. Stem cells, with their extraordinary ability

Is 3D Cell Culture Technology the Future of Biomedical Research?
Biotech & Bioprocessing Is 3D Cell Culture Technology the Future of Biomedical Research?

For more than a century, researchers have relied on two-dimensional (2D) methods to culture plant and animal cells in laboratories, confining cell growth to flat surfaces like tiny petri dishes. However, such methods impose significant limits on how cells grow and interact, often producing less

Global Experts Warn of Risks from Synthetic 'Mirror Bacteria'
Biotech & Bioprocessing Global Experts Warn of Risks from Synthetic 'Mirror Bacteria'

Imagine a world where synthetic organisms, known as mirror bacteria, thrive undetected due to their reversed molecular chirality, posing significant risks to human health and the environment. Researchers from diverse scientific fields, including immunology, ecology, and biosecurity, are raising

Building the Future: Why Biopharma Campuses Must Evolve
Editorial Building the Future: Why Biopharma Campuses Must Evolve

The life sciences industry has come a long way since the last COVID-19 outbreak. Today, organizations are prioritizing efficiency, speed, and innovation. That’s why biopharma and biotech companies are increasingly broadening their investments in physical spaces. Campuses and facilities are being r

Can Programmable Nanomachines Revolutionize Drug Delivery Systems?
Tech & Innovation Can Programmable Nanomachines Revolutionize Drug Delivery Systems?

The field of nanotechnology is rapidly evolving, with significant advancements being made in the development of nanomachines—tiny biological devices capable of performing complex functions within living organisms. These innovations hold the potential to revolutionize various fields, particularly d

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later